Healthcare provider profile · identity verified

Ghaleb S 'Michael' Sabbah, MD

Internal Medicine · PALM SPRINGS, CA · NPI 1376525824

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	369	143
Amlodipine Besylate	Amlodipine Besylate	243	89
Lisinopril	Lisinopril	234	94
Levothyroxine Sodium	Levothyroxine Sodium	163	71
Losartan Potassium	Losartan Potassium	153	56
Metformin Hcl	Metformin Hcl	139	53
Gabapentin	Gabapentin	122	35
Furosemide	Furosemide	103	34
Metoprolol Succinate	Metoprolol Succinate	92	36
Tamsulosin Hcl	Tamsulosin Hcl	82	24
Potassium Chloride	Potassium Chloride	76	23
Pantoprazole Sodium	Pantoprazole Sodium	74	32
Eliquis	Apixaban	71	23
Rosuvastatin Calcium	Rosuvastatin Calcium	70	30
Metoprolol Tartrate	Metoprolol Tartrate	68	27
Trazodone Hcl	Trazodone Hcl	63	28
Duloxetine Hcl	Duloxetine Hcl	59	12
Sertraline Hcl	Sertraline Hcl	59	21
Clopidogrel	Clopidogrel Bisulfate	57	22
Omeprazole	Omeprazole	53	23
Carvedilol	Carvedilol	49	17
Pravastatin Sodium	Pravastatin Sodium	49	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	13
Albuterol Sulfate Hfa	Albuterol Sulfate	44	24
Escitalopram Oxalate	Escitalopram Oxalate	44	21
Ezetimibe	Ezetimibe	44	13
Hydrochlorothiazide	Hydrochlorothiazide	44	23
Simvastatin	Simvastatin	39	20
Fluticasone Propionate	Fluticasone Propionate	38	25
Montelukast Sodium	Montelukast Sodium	35	11
Mirtazapine	Mirtazapine	34	11
Donepezil Hcl	Donepezil Hcl	32	11
Finasteride	Finasteride	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Glipizide	Glipizide	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Allopurinol	Allopurinol	27	15
Alendronate Sodium	Alendronate Sodium	25	11
Famotidine	Famotidine	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	11
Dapagliflozin	Dapagliflozin Propanediol	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	11
Atenolol	Atenolol	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Nifedipine Er	Nifedipine	18	suppressed
Cephalexin	Cephalexin	17	16
Tramadol Hcl	Tramadol Hcl	17	13
Levetiracetam	Levetiracetam	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Azithromycin	Azithromycin	14	14
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error